Advagene Biopharma Co., Ltd. (TPEX:6709)
29.95
-0.90 (-2.92%)
Mar 10, 2026, 12:39 PM CST
25.05% (1Y)
| Market Cap | 1.83B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -71.10M |
| Shares Out | 59.38M |
| EPS (ttm) | -1.23 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,704 |
| Average Volume | 133,018 |
| Open | 30.05 |
| Previous Close | 30.85 |
| Day's Range | 29.95 - 30.30 |
| 52-Week Range | 15.75 - 41.00 |
| Beta | 0.77 |
| RSI | 46.22 |
| Earnings Date | Mar 20, 2026 |